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ABSTRACT 
Objective: To develop a simple, rapid, accurate, robust and inexpensive spectrophotometric method for the estimation of benidipine hydrochloride 
by using quality by design (QbD)” approach. 
Methods: A UV spectrophotometric method was developed on Shimadzu UV-1800 double beam spectrophotometer using methanol as solvent and 
wavelength of 236 nm was selected as absorbance maxima (max). Effect of input variables on spectrum characteristics were studied for the 
selection of critical parameters and proposed method was validated for various parameters like system suitability, linearity, precision, accuracy, 
detection limits and quantification limits as per the International Conference on Harmonization guidelines ICH Q2(R1).  
Results: Linearity of the method was found to be excellent over the concentration range 3 to 18 µg/ml with high correlation coefficient value of 
0.9999. Limits of detection and quantification were found to be 0.20 µg/ml and 0.60 µg/ml respectively. The mean recovery was found to be 100.35 
% with low percentage relative standard deviation (% RSD) value. The precision study also has shown low % RSD value (<1). No interfering peaks 
were observed during specificity studies. 
Conclusion: Obtained result indicated that the developed spectrophotometric method is robust and efficient for the determination of benidipine 
hydrochloride. 
Keywords: Quality by design, Analytical quality by design, Benidipine hydrochloride estimation, Analytical method validation, Spectrophotometric 
estimation 




The benidipine hydrochloride (BEN) is a calcium channel blocker. It 
is used orally as an anti-anginal and antihypertensive agent. Its 
chemical name is (±)-(R*)-3-[(R*)-1-benzyl-3-piperidyl] methyl 1,4-
dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridine dicarboxylate 
hydrochloride [1]. 
Concept quality by design (QbD) is used for the development of 
pharmaceutical processes to ensure a predefined product quality [2]. 
QbD concepts are explained in International Conference on 
Harmonization (ICH) guidelines Q8 (R1) (Pharmaceutical Development), 
Q9 (Quality risk management), and Q10 (Pharmaceutical quality system) 
[3-5]. ICH Q8 (R1) guideline defines QbD as “a systematic approach to 
development that begins with predefined objectives and emphasizes 
product and process understanding and process control, based on sound 
science and quality risk management” [6]. QbD is a systematic approach 
to product development through an understanding of the effects of 
various input variables (e. g. process parameters, materials) on the final 
product (active pharmaceutical ingredient or drug product). Thus, QbD 
approach defines appropriate ranges of the input parameters within 
which the quality of the final product is assured [7]. In a similar manner 
for analytical methods, QbD approach involves a full understanding of 
how the analytical technique attributes and operating conditions affect 
the analytical performance. Factors to study in” analytical quality by 
design” (AQbD) approach may include the type of analytical technique 
chosen, reagents used, and instrumental parameters [8].  
There are similar advantages of applying QbD principles to 
analytical methods as to manufacturing processes and product [9]. 
Several researchers have implemented QbD principles to analytical 
methods development process [10-15]. AQbD approach can be used 
in the development of a robust and cost-effective analytical method 
which is applicable at any stage of the lifecycle of the product. Some 
regulatory authorities have recently provided flexibility of changing 
analytical method without revalidation if the AQbD approach has 
been implemented during analytical method development [16].  
The first stage of AQbD approach is to set an analytical target profile 
(ATP) for the method. ATP defines the goal of the analytical method 
development process and it is the indicators of method 
performance. ICH guidelines on validation of analytical procedures, 
ICH Q2(R1), has given various method performance characteristics 
for an analytical method [16]. Thus, a QbD based UV spectrometric 
method can be developed by considering the ICH guidelines Q2 (R1). 
The goal of the present investigation was to developed a simple, 
rapid, robust, flexible and economical UV spectrometric method for 
the estimation of benidipine hydrochloride by using analytical 
quality by design (AQbD)” approach. For implementing QbD 
approach to UV spectrophotometric analytical method, the effect of 
method input variables on spectral shape, intensity of absorbance, 
and absorbance maxima (max), were studied and critical 
parameters were selected for the proposed method. Then proposed 
method was validated as per the ICH guidelines ICH Q2(R1). 
MATERIALS AND METHODS 
Equipment and chemicals 
UV Spectrophotometer (Shimadzu UV-1800 double beam spectro-
photometer). Benidipine hydrochloride (BEN) was purchased from 
Niksan pharmaceutical Ahmedabad, India. All other chemicals used 
were of analytical reagent grade.  
Preparation of stock and working solution  
The solubility of BEN in different solvents such as distilled water, 
0.01N sodium hydroxide, 0.01N hydrochloric acid, and methanol 
was determined. The maximum solubility of BEN was found to be in 
methanol. Hence methanol is used for the preparation of standard 
stock and working solutions. The stock solution was prepared by 
dissolving 25 mg of BEN in 25 ml methanol to obtain 1000 g/ml 
concentration. Standard working solution of 10 g/ml was prepared 
from stock solution by dilution and used for initial spectral scan in 
the UV spectrophotometer. 
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Determination of wavelength of maximum absorption 
Standard working solution (10 g/ml) of BEN was scanned from 
200-400 nm in the UV spectrophotometer for the selection of 
analytical wavelength. BEN showed maximum absorbance (max) at 
236 nm (fig. 1). Hence 236 nm was selected as analytical 
wavelength.  
Implementation of AQbD approach in the development of the 
analytical method 
For AQbD approach, Ishikawa diagram was used to study the 
relationship between variable input parameters and the method 
performance characteristics of the spectrophotometric analytical 
methods [8] (fig. 2). 
 
 
Fig. 1: UV spectrum of benidipine hydrochloride showing maximum absorbance (max) at 236 nm 
 
 
Fig. 2: Ishikawa diagram showing the relationship between variable input parameters and the method performance characteristics of the 
spectrophotometric analytical methods 
 
 
Fig. 3: Overlay UV spectrum at varied scan speed (fast, medium, slow, and very slow) and varied sampling interval (0.1, 0.2, 0.5, 1.0, and 2.0 nm) 
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The solvent selection was based on the maximum solubility of BEN. 
The maximum solubility of BEN was found to be in methanol hence 
methanol was selected as a solvent for a UV spectrophotometer 
analytical method of BEN. For all other variable parameters that are 
shown in Ishikawa diagram, the absorbance spectrums were 
recorded by scanning standard working solution (10 g/ml) in the 
selected solvent from 200-400 nm in the UV spectrophotometer.  
Spectral shape, sharpness, and absorbance intensity of spectrum 
were recorded and compared at varied scan speed such as fast, 
medium, slow, and very slow and varied sampling interval was 
such as of 0.1, 0.2, 0.5, 1.0, and 2.0 nm [17]. As shown in fig. 3 
spectrums were overlapping each other. Thus, indicating no 
significant changes in spectral shape, sharpness, and absorbance’s 
intensity of spectrum due to variation in scan speed and sampling 
interval. 
On the basis of above observation, the critical parameters were 
selected (table 1) and by using selected variable parameters, method 
is further validated as per the ICH guidelines Q2(R1). 
 
Table 1: Selected critical parameter for spectrophotometric analytical method of BEN 
Parameter Selected variables 
Wavelength 236 nm 
Solvent Methanol 
Scan speed Fast 
Sampling interval 0.2 nm 
 
Validation 
The selected critical parameters should comply with method 
performance characteristics of an analytical method in order to 
achieve analytical target profile of method. ICH has laid down 
various method performance characteristics for an analytical 
method in ICH guidelines Q2 (R1). Thus, for a spectrophotometric 
analytical method, it is appropriate to validating method according 
to ICH guidelines Q2(R1) on the selected critical parameter in order 
to implement AQbD approach.  
Hence by using selected critical parameters, developed method is further 
validated as per the ICH guidelines Q2(R1) [6]. The characteristics 
studied were system suitability, linearity, precision, accuracy, specificity, 
limit of detection (LOD) and limit of quantification (LOQ). 
System suitability 
System suitability is done to demonstrate the suitability of the UV 
spectrophotometer system being used for the analysis. Six replicates 
of standard solution (10 g/ml) of BEN were prepared from a stock 
solution in the selected solvent (methanol) and absorbance was 
determined at 236 nm of each replicate using UV spectro-
photometer. Percentage relative standard deviation (% RSD) was 
calculated for the absorbances [6]. 
Linearity 
According to the ICH guidelines, the linearity of an analytical 
procedure determines that the test results are directly proportional 
to the concentration (amount) of analyte in the sample. For linearity 
study, six solutions of different concentrations (3, 6, 9, 12, 15 and 18 
µg/ml) were prepared in methanol from a standard stock solution of 
BEN and absorbance of each solution was noted at 236 nm in 
triplicate. The calibration curve was prepared by plotting the 
absorbance against concentration and % RSD, and the correlation 
coefficient was calculated by regression analysis [6]. 
Precision  
According to the ICH guidelines, the precision of an analytical 
procedure determines the closeness of results obtained by multiple 
measurements of the same homogeneous sample. Repeatability 
(intra-day precision) and intermediate precision (inter-day 
precision) were done to show the precision of the method. 
To demonstrate repeatability (intra-day precision) of the test method, 
six replicates of the 10 g/ml concentration (n=6) were analyzed on 
the same day. % RSD of assay result of six replicates was calculated. 
Similarly, for intermediate precision (inter-day precision), six 
replicates of the 10 g/ml concentrations were analyzed for assay on 
three consecutive days and % RSD was calculated [6]. 
Accuracy 
The accuracy of an analytical procedure shows the closeness of 
results with the conventional true value. Accuracy was determined 
by recovery study of BEN. To the known amount of standard 
solution (10g/ml), a known amount of standard stock solution was 
added at a different level, i.e. 50%, 100%. and 150% to get final 
concentration of 15 g/ml, 20 g/ml, and 25 g/ml. then these 
solutions were reanalyzed for drug content. Triplicate set of each 
levels were prepared for the experiment. The recovery of sample, 
and % RSD, were calculated [6]. 
Limit of detection (LOD) and limit of quantification (LOQ) 
Limit of detection is the lowest amount of analyte in a sample that can be 
detected, but not necessarily quantified as an exact value and limit of 
quantification is the lowest concentration of an analyte in the sample 
that can be determined with accuracy and precision. Limit of detection 
and limit of quantification concentrations for BEN were determined 
based on the residual standard deviation of response and slope method 
as per ICH guideline. Calibration curve prepared in linearity study was 
used for this purpose. For LOD calculation equation (3.3 x )/S and for 
LOQ equation (10 x )/S was used. Where σ is the standard deviation of 
the response and S is the slope of the calibration curve [6]. 
Specificity 
According to ICH guideline specificity is the ability to determine the 
analyte in the presence of possible components which can be 
present such as impurities, degradants, excipients, etc. To show 
specificity spectra of standard solution (10 µg/ml), diluent and 
common pharmaceutical excipient (oil and surfactant mixture) were 
compared [6]. 
RESULTS AND DISCUSSION  
System suitability 
The absorbance of six replicate of standard solution (10 g/ml) of 
BEN is reported table 2. For system suitability % RSD of absorbance 
of replicate solutions is should not more than 2 [18]. The results 
obtained was meets the system suitability requirements, this 
indicates that the system was suitable for the analysis [19]. 
Linearity 
The calibration plot of absorbance versus concentration was found 
to be linear over the concentration range of 3 to 18 µg/ml as shown 
in fig. 4 and fig. 5. RSD was found to have small value 0.00283% 
while correlation coefficient (r2) have high value 0.9999 (table 3). 
Thus, indicating that test results were directly proportional to the 
concentration (amount) of analyte in the sample [20-21]. 
Precision 
The calculated RSD of intra-day and inter-day precision test are reported 
in table 4. For a precise analytical method, the % RSD of assay results of 
six replicates should not more than 2. The RSD of the intra-day assay of 
six replicates was 0.63% and for interday assay, RSD were 0.82%, 
0.98%, and 0.56% respectively for three consecutive days. Low % RSD 
value indicates that method was precise [22-23]. 
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Table 2: Result of system suitability studies 









% RSD 0.680758 
SD-standard deviation, RSD-relative standard deviation 
 
 
Fig. 4: Calibration curve plot of benidipine hydrochloride at 236 nm 
 
 
Fig. 5: Overly spectra of benidipine hydrochloride (3 to18 µg/ml) at 236 nm 
 
Table 3: Result of linearity study of benidipine hydrochloride 








% RSD 0.00283 
Linear regression equation y = 0.0507x+0.0339 
*mean±SD, n=3, SD-standard deviation, RSD-relative standard deviation 
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Table 4: Result of precision studies 

















%RSD Conc. found* 
(μg/ml) 
mean±SD (n=6) 




10 10.15±0.06 0.63 10 10.13±0.08 0.82 10.17±0.10 0.98 10.09±0.06 0.56 
*mean±SD, n=6, SD-standard deviation, RSD-relative standard deviation 
 
Accuracy  
The purpose of this experiment was to prove the trueness of the 
assay results obtained by the proposed method. The results of 
recovery studies are reported in table 5. The mean recovery was 
found to be 100.35% with low RSD value of 1.28 (<2 %).  
These results demonstrate the accuracy of the method [24-25]. 
 
Table 5: Result of accuracy studies 





















Mean % recovery of 3 




10 0 0 9.92±0.10 9.92 - - - 
50 5 15.01±0.17 5.09 101.8 100.35 1.28 
100 10 19.91±0.18 9.99 99.89 
150 15 24.97±0.34 15.05 99.36 
*mean±SD, n=3, SD-standard deviation, RSD-relative standard deviation 
 
Limit of detection (LOD) and limit of quantification (LOQ) 
By using calibration curve, the standard deviation of the response 
(σ) and slope of the calibration curve (S) was determined and 
calculation was carried out using equations (3.3 x )/S for LOD 
and (10 x )/S for LOQ. The LOD was found to be 0.20 µg/ml and 
the LOQ was found to be 0.60 µg/ml. Results are reported in table 
6. These results indicated the high sensitivity of the proposed UV 
method [26]. 
Specificity 
For a specific analytical method, there should be no interfering peak of 
diluent and possible excipient with the analyte [27]. Fig. 6 shows that no 
interfering peaks were observed during analysis. Hence method was 
specific. 
 
Table 6: Limit of detection (LOD) and limit of quantification (LOQ) determination 
Parameter Observed value 
Slope of regression(S) 0.0507 
Residual standard deviation (σ) 0.003046 
LOD concentration (µg/ml) 0.20 
LOQ concentration (µg/ml) 0.60 
 
 
Fig. 6: Specificity studies by comparing the spectra of benidipine hydrochloride, possible pharmaceutical excipient, and diluent (solvent) 
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A simple, rapid, sensitive, accurate, precise and inexpensive spectro-
photometric method was developed for estimation of benidipine 
hydrochloride in bulk by using analytical quality by design” (AQbD) 
approach. On the basis of an investigation of the effect of method input 
variables on absorbance pattern, the critical parameters have been 
selected for proposed method and it was further validated as per the 
ICH guidelines. The developed method does not involve complexity 
thus have an economic advantage over common chromatographic 
methods. Therefore, developed spectrophotometric method can be 
used flexibly and efficiently for the determination of benidipine either 
in bulk or in the dosage formulations. 
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